Galapagos NV
GLPG
#4634
Rank
C$2.79 B
Marketcap
C$42.42
Share price
-0.77%
Change (1 day)
10.80%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: C$2.79 Billion

As of December 2025 Galapagos NV has a market cap of C$2.79 Billion. This makes Galapagos NV the world's 4634th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025C$2.79 B8.27%
2024C$2.58 B-27.34%
2023C$3.55 B-10.39%
2022C$3.96 B-14.84%
2021C$4.65 B-43.61%
2020C$8.25 B-53.21%
2019C$17.64 B158.07%
2018C$6.83 B13.23%
2017C$6.03 B50.78%
2016C$4.00 B17.11%
2015C$3.41 B416.31%
2014C$0.66 B-0.73%
2013C$0.66 B18.72%
2012C$0.56 B54.89%
2011C$0.36 B-14.68%
2010C$0.42 B58.56%
2009C$0.26 B114.65%
2008C$0.12 B

End of Day market cap according to different sources

On Dec 15th, 2025 the market cap of Galapagos NV was reported to be:

C$2.81 Billion
by Nasdaq info icon info icon
C$2.81 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
C$385.72 B 13,699.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
C$694.26 B 24,738.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$159.37 B 5,602.01%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
C$540.40 B 19,234.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
C$0.14 B-94.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$303.87 B 10,771.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$47.40 B 1,596.19%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
C$135.19 B 4,736.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$336.38 B 11,934.96%๐Ÿ‡บ๐Ÿ‡ธ USA